Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 3/20 | 0.32 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL347366 | 0.75 | CYP2C19 (0.46) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL9483954 | 0.74 | ALDH1A1 (0.46) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL21647263 | 0.74 | ALDH1A1 (0.46) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL28390182 | 0.72 | ALDH1A1 (0.43) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL7516558 | 0.72 | ALDH1A1 (0.43) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL108616 | 0.72 | ALDH1A1 (0.43) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL1414703 | 0.72 | ALDH1A1 (0.43) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL1641737 | 0.71 | ALDH1A1 (0.39) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL12189845 | 0.71 | CYP2D6 (0.38) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL5809750 | 0.70 | ALDH1A1 (0.42) | ALDH1A1CYP2D6TSHRCYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113230210-B | Preparation method of pamidronate disodium injection | 苏州天马医药集团天吉生物制药有限公司 | 2022-10-04 | — | — | CN | claimed |
| US-20260061022-A1 | POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GI INNOVATION, INC. (KR) | 2026-03-05 | — | — | US | disclosed |
| US-12409203-B2 | Polypeptide dimer with high sialic acid content, comprising extracellular domain of alpha subunit of IGE FC receptor, and pharmaceutical composition comprising same | GI INNOVATION, INC. (KR) | 2025-09-09 | — | — | US | disclosed |
| CN-113447541-B | Biosensor and use the same method for measuring biosensor | 爱科来株式会社 | 2025-06-13 | — | — | CN | disclosed |
| CN-119639342-B | Red sandstone cultural relic weather-proof coating and preparation method thereof | 西南石油大学 | 2025-05-06 | — | — | CN | disclosed |
| US-20240174741-A1 | IL-38-SPECIFIC ANTIBODIES | IMMUNOME, INC. | 2024-05-30 | — | — | US | disclosed |
| EP-4313131-A1 | IL-38-SPECIFIC ANTIBODIES | Immunome, Inc. (US) | 2024-02-07 | — | — | EP | disclosed |
| CN-114096225-B | Oral care compositions comprising Jiang Erchun and methods of making the same | 联合利华知识产权控股有限公司 | 2023-11-14 | — | — | CN | disclosed |
| CN-111733281-B | Molecular marker for identifying peroxidase activity of wheat grains and application thereof | 新疆农业大学 | 2022-12-02 | — | — | CN | disclosed |
| WO-2022213050-A1 | IL-38-SPECIFIC ANTIBODIES | IMMUNOME, INC. (US) | 2022-10-06 | — | — | WO | disclosed |
| US-20220275077-A1 | IL-38-SPECIFIC ANTIBODIES | IMMUNOME, INC. | 2022-09-01 | — | — | US | disclosed |
| US-20220257693-A1 | POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GI INNOVATION, INC. (KR) | 2022-08-18 | — | — | US | disclosed |
| EP-4003420-A1 | IL-38-SPECIFIC ANTIOBODIES | Immunome, Inc. (US) | 2022-06-01 | — | — | EP | disclosed |
| EP-3998279-A1 | POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | GI Innovation, Inc. (KR) | 2022-05-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220257693-A1 | POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | FCGR2A, FCGR1A, FCER2 | ALDH1A1 2954/4885CYP2D6 3284/4885TSHR 524/4885 |
| US-12409203-B2 | Polypeptide dimer with high sialic acid content, comprising extracellular domain of alpha subunit of IGE FC receptor, and pharmaceutical composition comprising same | FCGR2A, FCGR1A, FCER2 | ALDH1A1 2954/4885CYP2D6 3284/4885TSHR 524/4885 |
| US-20260061022-A1 | POLYPEPTIDE DIMER WITH HIGH SIALIC ACID CONTENT, COMPRISING EXTRACELLULAR DOMAIN OF ALPHA SUBUNIT OF IGE FC RECEPTOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | FCER2, FCGR2A, FCGR1A | ALDH1A1 2537/4885CYP2D6 2157/4885TSHR 215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.